Protagenic Therapeutics Inc (NASDAQ:PTIX) currently has a daily average trading volume of 440.98K but it saw 754968 shares traded in last market. With a market cap of 2.06M USD, the company’s current market price of $3.50 came rising about 15.13 while comparing to the previous closing price of $3.04. In past 52 weeks, the stock remained buoying in the range of price level as high as $26.18 and as low as $2.35.
Taking a look at 20-day trading activity of Protagenic Therapeutics Inc (PTIX) gives us an average price of $3.35, while its current price level is -86.63% below from 52-week high level whereas it is 48.94% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.73 while that of 200 days or SMA-200 reads an average of $6.90. A closer look into the stock’s movement over the week reveals that its volatility is standing at 25.59% during that period while stretching the period over a month that decreases to 16.60%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 50.82 which implies that the stock is in neutral territory.
Over the week, PTIX’s stock price is moving 2.92% up while it is -8.86% when we observe its performance for the past one month. Year-to-date it is -48.98% down and over the past year, the stock is showing a downside performance of -81.82%.
Currently, Protagenic Therapeutics Inc’s total number of outstanding shares is 0.52M with 16.54% of that held by the insiders while 4.73% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -545.36% and return on equity (ROE) at -236.06%. Stock has a price to book (P/B) ratio of 1.79. Its return on asset (ROA) is -175.99% on average.
